STOCK TITAN

Clene (NASDAQ: CLNN) director granted 3,564 stock options at $6.81 exercise price

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clene Inc. director Vallerie McLaughlin received stock option awards as equity compensation. On May 21, 2026, she was granted options covering a total of 3,564 shares of common stock at an exercise price of $6.81 per share under the Clene Inc. Amended 2020 Stock Plan.

One option grant for 2,064 shares vests immediately, giving her the right to purchase those shares at the set price. A second option grant for 1,500 shares vests in 12 equal monthly installments on the 21st of each month starting June 21, 2026, extending through the following year. Both option series expire on May 20, 2036 if not exercised.

Positive

  • None.

Negative

  • None.

Insights

Routine director stock option grants with staged vesting and long-term expiry.

Clene Inc. granted director Vallerie McLaughlin stock options over 3,564 shares of common stock at an exercise price of $6.81 per share. These awards are classified as grants, not open-market purchases or sales, and represent standard equity-based compensation.

One 2,064-share grant vests immediately, while a 1,500-share grant vests monthly over 12 months starting June 21, 2026, with both expiring on May 20, 2036. The filing shows no option exercises or share sales, and derivative positions beyond these awards are not listed. Overall, the transactions appear routine and do not by themselves signal a change in outlook.

Insider McLaughlin Vallerie
Role null
Type Security Shares Price Value
Grant/Award stock option 1,500 $0.00 --
Grant/Award stock option 2,064 $0.00 --
Holdings After Transaction: stock option — 1,500 shares (Direct, null)
Footnotes (1)
  1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.
Total options granted 3,564 options Director stock option awards on May 21, 2026
Exercise price $6.81 per share Strike price for all reported options
Immediate vesting grant 2,064 options Vests in full on grant date May 21, 2026
Monthly vesting grant 1,500 options Vests in 12 equal installments starting June 21, 2026
Option expiration May 20, 2036 Expiration date for both option grants
Underlying shares (immediate) 2,064 shares Common stock underlying immediate vesting option
Underlying shares (monthly) 1,500 shares Common stock underlying monthly vesting option
stock option financial
"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"at an exercise price of $6.81 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Amended 2020 Stock Plan financial
"under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share"
vests immediately upon grant financial
"The options vest immediately upon grant."
vest in 12 equal monthly installments financial
"The options vest in 12 equal monthly installments on the 21st day of each calendar month"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McLaughlin Vallerie

(Last)(First)(Middle)
6550 SOUTH MILLROCK DRIVE
SUITE G50

(Street)
SALT LAKE CITY UTAH 84121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
stock option$6.8105/21/2026A1,500 (1)05/20/2036common stock1,500$01,500D
stock option$6.8105/21/2026A2,064 (2)05/20/2036common stock2,064$02,064D
Explanation of Responses:
1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.
2. This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.
/s/ Jerome T. Miraglia POA05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clene (CLNN) director Vallerie McLaughlin report in this Form 4?

She reported receiving stock option grants for 3,564 Clene common shares. The options were awarded as equity compensation under the Amended 2020 Stock Plan, with a fixed exercise price of $6.81 per share and a long-term expiration in May 2036.

How many Clene (CLNN) shares are covered by McLaughlin’s new stock options?

The grants cover options on 3,564 shares of Clene common stock. One grant is for 2,064 shares that vest immediately, and a second grant is for 1,500 shares that vest in 12 equal monthly installments starting June 21, 2026.

What is the exercise price and expiration date of McLaughlin’s Clene (CLNN) options?

All reported options have an exercise price of $6.81 per share and expire on May 20, 2036. She can choose to exercise any vested portion before that date to purchase Clene common stock at the fixed price.

How do the vesting terms work for McLaughlin’s new Clene (CLNN) stock options?

The 2,064-share grant vests fully on the grant date. The 1,500-share grant vests in 12 equal monthly installments on the 21st of each month, beginning June 21, 2026, gradually increasing her exercisable options over one year.

Does this Clene (CLNN) Form 4 show any stock sales or open-market purchases?

No, it only shows stock option grants classified as award acquisitions. There are no open-market buy or sell transactions reported, and no tax-withholding or gift transactions are indicated in this filing.